ESTA · Establishment Labs Holdings Inc
$92.32
-0.22% last session
End-of-day data · updated 2026-07-28
Market cap
$3B
Enterprise value
$3B
Trailing P/E
—
Forward P/E
1,228.0
Dividend yield
—
Beta
1.07
Avg volume
1M
Employees
1K
2D change
—
5D change
1.10%
10D change
-0.52%
30D change
4.21%
60D change
30.29%
MTD change
3.22%
YTD change
26.37%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — ESTA
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-15
Latest call per bank · past 12 months
Citigroup
Neutral$92.00
-0.3% vs priceJP Morgan
Overweight$80.00
-13.3% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-15 | Mizuho | Maintains | Outperform | $100 → $105 |
| 2026-07-08 | Citigroup | Maintains | Neutral | $76.00 → $92.00 |
| 2026-05-07 | BTIG | Maintains | Buy | $88.00 → $90.00 |
| 2026-04-29 | BTIG | Reiterates | Buy | $88.00 |
| 2026-03-11 | Citigroup | Maintains | Neutral | $81.00 → $74.00 |
| 2026-02-26 | Canaccord Genuity | Maintains | Buy | $85.00 → $90.00 |
| 2026-02-25 | Stephens & Co. | Maintains | Overweight | $85.00 → $90.00 |
| 2026-02-25 | Mizuho | Maintains | Outperform | $90.00 → $100 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 59 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 11.8% above the 50-day MA ($82.19).
- Price vs 200-day MA: Trading 32.1% above the 200-day MA ($69.57).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.37) — short-term momentum is fading.
- 52-week range: Price is within 5% of the 52-week high ($95.65).
ESTA Price Chart
Loading chart for ESTA…
Fundamentals
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
More in Medical Devices
ABT
Abbott Laboratories
$182B -15.0% YTD
SYK
Stryker Corporation
$129B -3.7% YTD
MDT
Medtronic plc.
$108B -10.8% YTD
BSX
Boston Scientific Corporation
$68B -52.3% YTD
EW
Edwards Lifesciences Corporatio
$48B -2.6% YTD
GEHC
GE HealthCare Technologies Inc.
$28B -25.4% YTD
DXCM
DexCom, Inc.
$28B 10.5% YTD
PHG
Koninklijke Philips N.V. NY Reg
$24B -4.0% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.